J R Fraser Cummings (Jr Fraser Cummings, Fraser Cummings, J R F Cummings)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

BMJ open gastroenterology

Frontline gastroenterology

International journal of clinical pharmacy

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

David Young, Clare Harris, Sohail Rahmany, Inês Iria, João Gonçalves, Janet Addison, Justin Harvey, Susan Latter, J R Fraser Cummings
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS). International journal of clinical pharmacy (2024)
Mohammed Nabil Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, Shahida Din, Ruth Wakeman, J R Fraser Cummings, Shaji Sebastian, Stuart Bloom, Jimmy K Limdi, Anjan Dhar, R Alexander Speight, Keith Bodger, Nicholas A Kennedy, null null, Christopher Andrew Lamb, Ian D Arnott, Christian P Selinger
Establishing key performance indicators for inflammatory bowel disease in the UK. Frontline gastroenterology 14 (5) (2023)
Ran Jin, Chidozie U Nduka, Delphine Courmier, Hannah Knight, Rachael Meadows, James Piercy, J R Fraser Cummings, Waldemar Radziszewski
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe. Advances in therapy (2023)
Neil Chanchlani, Simeng Lin, Marcus Karl-Heinz Auth, Chai Leng Lee, Helena Robbins, Shi Looi, Senthil V Murugesan, Tom Riley, Cathryn Preston, Sophie Stephenson, Wendy Cardozo, Sunil A Sonwalkar, Mohammed Allah-Ditta, Lynne Mansfield, Dharmaraj Durai, Mark Baker, Ian London, Emily London, Sanjay Gupta, Alex Di Mambro, Aisling Murphy, Edward Gaynor, Kelsey D J Jones, Andrew Claridge, Shaji Sebastian, Sankaranarayanan Ramachandran, Christian Philipp Selinger, Simon P Borg-Bartolo, Paul Knight, Michael B Sprakes, Julie Burton, Patricia Kane, Stephanie Lupton, Aimee Fletcher, Daniel R Gaya, Roghan Colbert, John Paul Seenan, Jonathan Macdonald, Lucy Lynch, Iain McLachlan, Stephanie Shields, Richard Hansen, Lisa Gervais, Mwansa Jere, Muhammad Akhtar, Karen Black, Paul Henderson, Richard Kay Russell, Charlie W Lees, Lauranne A A P Derikx, Melanie Lockett, Frederica Betteridge, Aminda De Silva, Arif Hussenbux, John Beckly, Oliver Bendall, James W Hart, Amanda Thomas, Benjamin Hamilton, Claire Gordon, Desmond Chee, Timothy James McDonald, Rachel Nice, Marian Parkinson, Helen Gardner-Thorpe, Jeff R Butterworth, Asima Javed, Sarah Al-Shakhshir, Rekha Yadagiri, Sebrene Maher, Richard C G Pollok, Tze Ng, Priscilla Appiahene, Fiona Donovan, James Lok, Rajiv Chandy, Reema Jagdish, Daniyal Baig, Zahid Mahmood, Liane Marsh, Allison Moss, Amin Abdulgader, Angus Kitchin, Gareth J Walker, Becky George, Yuen-Hui Lim, James Gulliver, Stuart Bloom, Holly Theaker, Sean Carlson, J R Fraser Cummings, Robert Livingstone, Amanda Beale, Josiah O Carter, Andrew Bell, Archibald Coulter, Jonathon Snook, Helen Stone, Nicholas Alexander Kennedy, James R Goodhand, Tariq Ahmad, null null
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study. Alimentary pharmacology & therapeutics 56 (8) (2022)
Matthew Stammers, Sohail Rahmany, Louise Downey, Florina Borca, Clare Harris, Richard Harris, Martin McDonnell, Stephanie Sartain, Nicolas Coleman, Bernard Stacey, Trevor R Smith, J R Fraser Cummings, Richard Felwick, Markus Gwiggner
Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study. Frontline gastroenterology 13 (6) (2022)
David Young, J R Fraser Cummings, Susan Latter
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study. European journal of hospital pharmacy : science and practice (2022)
Fabio Salvatore Macaluso, J R Fraser Cummings, Raja Atreya, Jaeyun Choi, Ambrogio Orlando
A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical Data to Real-World Evidence. Expert opinion on biological therapy (2021)
Martin McDonnell, Richard J Harris, Florina Borca, Tilly Mills, Louise Downey, Suranga Dharmasiri, Mayank Patel, Benjamin Zare, Matt Stammers, Trevor R Smith, Richard Felwick, J R Fraser Cummings, Hang T T Phan, Markus Gwiggner
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. BMJ open gastroenterology 7 (1) (2021)
J R Fraser Cummings, Aileen Fraser, Catherine Stansfield, Ian Beales, Shaji Sebastian, Sami Hoque
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK. BMJ open gastroenterology 8 (1) (2021)
Nicholas Alexander Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Benjamin Hamilton, Claire M Bewshea, Rachel Nice, Desmond Chee, J R Fraser Cummings, Aileen Fraser, Peter M Irving, Nikolaos Kamperidis, Klaartje B Kok, Christopher Andrew Lamb, Jonathan Macdonald, Shameer J Mehta, Richard C G Pollok, Timothy Raine, Philip J Smith, Ajay Mark Verma, Simon Jochum, Timothy James McDonald, Shaji Sebastian, Charlie W Lees, Nicholas Powell, Tariq Ahmad, null null
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 70 (10) (2021)
HoUng Kim, Rieke E Alten, J R Fraser Cummings, Silvio Danese, Geert R A M D'Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, Jong Hyuk Lee, James O Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven R A Simoens, René Westhovens, Ji Hoon Jeong, Laurent Peyrin-Biroulet
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13 (1) (2021)
Richard James Harris, Louise Downey, Trevor R Smith, J R Fraser Cummings, Richard Felwick, Markus Gwiggner
Life in lockdown: experiences of patients with IBD during COVID-19. BMJ open gastroenterology 7 (1) (2020)